ADIPOQ and Glucose intolerance: Given that AP2 can target other cell types including Mφs, and that in the referring study, deletion of Fpn in ATMs was not confirmed, it is possible that the loss of Fpn in ATMs was responsible for the reduction in adiponectin and glucose intolerance.